On the 27th, the immuno-oncology theme rose by 3.19% compared to the previous day, showing strength, while CrystalGenomics, a related stock attracting attention, surged by 7.8% compared to the previous day. CrystalGenomics is known as a company specializing in new drug development, including treatments for arthritis and novel antibiotics.
[Graph] Price Fluctuations of Major Stocks in the Immuno-Oncology Theme
According to preliminary data compiled at 11:51, foreign investors have purchased 133,300 shares of CrystalGenomics, indicating a large net buying by foreigners.
[Table] Net Buying and Selling Volume by Foreigners and Institutions (Unit: 10,000 shares)
According to the analysis by Thinkpool RoboAlgorithm RASSI, CrystalGenomics’ quant financial score is 13.49 points, ranking 10th within the immuno-oncology theme, with higher growth and stability scores compared to the average of other related stocks. This indicates that, compared to other stocks in the theme, CrystalGenomics shows relatively fast growth in sales and net income, as well as good responsiveness to changes in domestic and international economic environments.
[Table] Top Stocks by Financial Score within the Theme
※ The quant financial score is the result of RoboAlgorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
